Literature DB >> 24084454

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype.

S Chekhun1, N Bezdenezhnykh, J Shvets, N Lukianova.   

Abstract

AIM: The aim of our study was to determine the complex of molecular genetic markers which are associated with cancer aggressiveness, invasion and metastasis among different molecular subtypes of breast cancer cell lines.
MATERIALS AND METHODS: The cell lines used in the analysis include T47D, MCF-7, MDA-MB-231, MDA-MB-468, MCF-10A and 184A1. Expression of estrogen receptor, progesterone receptor, Her-2/neu and Ki-67 was studied by immunocytochemical method. CD24, CD44 and E-cadherin expression was studied by flow cytometry.
RESULTS: We have identified biomarkers which characterize metastatic potential of human breast cancer cells of certain molecular subtypes. It has been demonstrated that low colony forming activity of human breast cancer cells of luminal subtype is accompanied by increased adhesive properties of these cells due to high level of E-cadherin expression, low level of CD44 expression and absence of CD24 expression. High tumorigenicity of cells of basal subtype is connected to weakening of adhesive contacts that is caused by abnormalities of E-cadherin expression, significant increase of CD44 expression and presence of low level of CD24 expression.
CONCLUSION: Our data indicated that changes of correlation between expression of cellular adhesion molecules inside conventional immunohistochemical subtypes reflect significantly wider biological properties of luminal and basal subtypes of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24084454

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  12 in total

1.  Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.

Authors:  Sucheta Chopra; Sumit Goel; Banita Thakur; Alka Bhatia
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

2.  Expression of MAS1 in breast cancer.

Authors:  Yi Luo; Eriko Tanabe; Misaho Kitayoshi; Yukiko Nishiguchi; Rina Fujiwara; Sayako Matsushima; Takamitsu Sasaki; Tomonori Sasahira; Yoshitomo Chihara; Dai Nakae; Kiyomu Fujii; Hitoshi Ohmori; Hiroki Kuniyasu
Journal:  Cancer Sci       Date:  2015-07-20       Impact factor: 6.716

3.  Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.

Authors:  Rosanna Aversa; Anna Sorrentino; Roberta Esposito; Maria Rosaria Ambrosio; Angela Amato; Alberto Zambelli; Alfredo Ciccodicola; Luciana D'Apice; Valerio Costa
Journal:  Int J Mol Sci       Date:  2016-01-16       Impact factor: 5.923

4.  Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.

Authors:  Johanna M Poller; Jan Zaloga; Eveline Schreiber; Harald Unterweger; Christina Janko; Patricia Radon; Dietmar Eberbeck; Lutz Trahms; Christoph Alexiou; Ralf P Friedrich
Journal:  Int J Nanomedicine       Date:  2017-04-19

5.  Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.

Authors:  Stephan Lugert; Harald Unterweger; Marina Mühlberger; Christina Janko; Sebastian Draack; Frank Ludwig; Dietmar Eberbeck; Christoph Alexiou; Ralf P Friedrich
Journal:  Int J Nanomedicine       Date:  2018-12-21

6.  Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women.

Authors:  Hien Minh Nguyen; Minh Quang Dao
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-03-18

7.  MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.

Authors:  Zhuxian Zhou; Mohammed Qutaish; Zheng Han; Rebecca M Schur; Yiqiao Liu; David L Wilson; Zheng-Rong Lu
Journal:  Nat Commun       Date:  2015-08-12       Impact factor: 14.919

8.  A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2.

Authors:  Shuang Zhao; S Laura Chang; Jennifer J Linderman; Felix Y Feng; Gary D Luker
Journal:  Transl Oncol       Date:  2014-05-13       Impact factor: 4.243

9.  Reduced expression of α-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients.

Authors:  Serena Bonin; Alessia Parascandolo; Cinzia Aversa; Renzo Barbazza; Nobuo Tsuchida; Maria Domenica Castellone; Giorgio Stanta; Giancarlo Vecchio
Journal:  Oncotarget       Date:  2018-02-07

10.  Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesis.

Authors:  Ju-Suk Nam; Ashish Ranjan Sharma; Lich Thi Nguyen; Supriya Jagga; Yeon-Hee Lee; Garima Sharma; Sang-Soo Lee
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.